Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ficus glomerata latex is a milky sap harvested from the *Ficus glomerata* tree, also widely known by its botanical synonym *Ficus racemosa* or the Cluster Fig. Traditionally used in Ayurvedic medicine, this latex contains a variety of bioactive constituents including the proteolytic enzyme ficin, lupeol, beta-sitosterol, and gluanol acetate. It is recognized for its hypoglycemic, anti-inflammatory, and antimicrobial activities. The latex is primarily indicated for the treatment of diabetes mellitus, diarrhea, hemorrhoids, and skin conditions such as boils and inflammatory wounds. Its therapeutic mechanism involves the enzymatic action of cysteine proteases (ficin) which aids in wound debridement and tissue repair, alongside secondary metabolites that modulate glucose metabolism and oxidative stress pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ficus glomerata latex.